Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism

Clinical Nuclear Medicine

Volumn 39, Issue 3, 2014, Pages

  Akdemir, Ümit Özgür ^a   Tokçaer, Ayşe Bora ^a   Karakuş, Asl ^b   Kapucu, Lütfiye Özlem ^a  

^a GAZI UNIVERSITY   (Turkey)

^b Kilis State Hospital   (Turkey)

Author keywords

differential diagnosis; glucose metabolism; Parkinson disease; parkinsonian disorders; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRADYKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PROGRESSIVE SUPRANUCLEAR PALSY; UNIFIED PARKINSON DISEASE RATING SCALE; ATROPHY; BRAIN; CLINICAL TRIAL; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; ATROPHY; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84894032978     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000315     Document Type: Article

References (31)

1. Brooks DJ. Imaging approaches to Parkinson disease. J Nucl Med. 2010;51:596-609.
2. Piccini P, Whone A. Functional brain imaging in the differential diagnosis of Parkinson's disease. Lancet Neurol. 2004;3:284-290. (Pubitemid 38510199)
3. Hughes AJ, Daniel SE, Ben-Shlomo Y, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861-870. (Pubitemid 34279780)
4. Tatsch K. Positron emission tomography in diagnosis and differential diagnosis of Parkinson's disease. Neurodegener Dis. 2010;7:330-340.
5. Lyoo CH, Jeong Y, Ryu YH, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain. 2008;131:438-446. (Pubitemid 351197623)
6. Berti V, Polito C, Ramat S, et al. Brain metabolic correlates of dopaminergic degeneration in de novo idiopathic Parkinson's disease. Eur J Nucl Med Mol Imaging. 2010;37:537-544.
7. Eckert T, Tang C, Ma Y, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord. 2008;23:727-733.
8. Spetsieris PG, Ma Y, Dhawan V, et al. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage. 2009;45:1241-1252.
9. 18F]fluorodeoxyglucose and PET. Mov Disord. 1998;13:268-274.
10. Claassen DO, Lowe VJ, Peller PJ, et al. Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy. Parkinsonism Relat Disord. 2011;17:160-165.
11. Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage. 2005;26:912-921. (Pubitemid 40825033)
12. 18F-FDG PET. Eur J Radiol. 2004;51:223-233. (Pubitemid 39037273)
13. Juh R, Pae CU, Lee CU, et al. Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Neurosci Res. 2005;52:211-219. (Pubitemid 40775759)
14. Klein RC, De Jong BM, De Vries JJ, et al. Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease. Mov Disord. 2005;20:1021-1030. (Pubitemid 41419520)
15. 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Mov Disord. 2007;22:2352-2358. (Pubitemid 351155980)
16. 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease. Eur J Neurol. 2008;15:1043-1049.
17. Lee PH, An YS, Yong SW, et al. Cortical metabolic changes in the cerebellar variant of multiple system atrophy: a voxel-based FDG-PET study in 41 patients. Neuroimage. 2008;40:796-801.
18. Mure H, Hirano S, Tang CC, et al. Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage. 2011;54:1244-1253.
19. Tang CC, Poston KL, Dhawan V, et al. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci. 2010;30:1049-1056.
20. Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9:149-158.
21. Teune LK, Bartels AL, De Jong BM, et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord. 2010;25:2395-2404.
22. Teune LK, Renken RJ, Mudali D, et al. Validation of parkinsonian disease-related metabolic brain patterns. Mov Disord. 2013;28:547-551.
23. Poston KL, Tang CC, Eckert T, et al. Network correlates of disease severity in multiple system atrophy. Neurology. 2012;78:1237-1244.
24. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes. Parkinsonism Relat Disord. 2012;18:S60-S62.
25. Eggers C, Hilker R, Burghaus L, et al. High resolution positron emission tomography demonstrates basal ganglia dysfunction in early Parkinson's disease. J Neurol Sci. 2009;276:27-30.
26. Berding G, Odin P, Brooks DJ, et al. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18) F]FDG-PET. Mov Disord. 2001;16:1014-1022. (Pubitemid 36041213)
27. Eidelberg D, Moeller JR, Ishikawa T, et al. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J Nucl Med. 1995;36:378-383.
28. Nagano-Saito A, Kato T, Arahata Y, et al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. Neuroimage. 2004;22:553-561. (Pubitemid 38759417)
29. Brooks DJ. Imaging end points for monitoring neuroprotection in Parkinson's disease. Ann Neurol. 2003;53:S110-S118.
30. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 2009;32:548-557.
31. Darcourt J, Booij J, Tatsch K, et al. EANM procedure guidelines for brain neurotransmission SPECT using (123) I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443-450.